199 related articles for article (PubMed ID: 18923147)
1. Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function.
Wojciak-Stothard B; Torondel B; Zhao L; Renné T; Leiper JM
Mol Biol Cell; 2009 Jan; 20(1):33-42. PubMed ID: 18923147
[TBL] [Abstract][Full Text] [Related]
2. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility.
Wojciak-Stothard B; Torondel B; Tsang LY; Fleming I; Fisslthaler B; Leiper JM; Vallance P
J Cell Sci; 2007 Mar; 120(Pt 6):929-42. PubMed ID: 17327280
[TBL] [Abstract][Full Text] [Related]
3. The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis.
Fiedler LR; Bachetti T; Leiper J; Zachary I; Chen L; Renné T; Wojciak-Stothard B
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2117-24. PubMed ID: 19778944
[TBL] [Abstract][Full Text] [Related]
4. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells.
Wojciak-Stothard B; Tsang LY; Haworth SG
Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L749-60. PubMed ID: 15591411
[TBL] [Abstract][Full Text] [Related]
5. Impaired integrin-mediated adhesion contributes to reduced barrier properties in VASP-deficient microvascular endothelium.
Schlegel N; Waschke J
J Cell Physiol; 2009 Aug; 220(2):357-66. PubMed ID: 19347869
[TBL] [Abstract][Full Text] [Related]
6. Vasodilator-stimulated phosphoprotein deficiency potentiates PAR-1-induced increase in endothelial permeability in mouse lungs.
Profirovic J; Han J; Andreeva AV; Neamu RF; Pavlovic S; Vogel SM; Walter U; Voyno-Yasenetskaya TA
J Cell Physiol; 2011 May; 226(5):1255-64. PubMed ID: 20945373
[TBL] [Abstract][Full Text] [Related]
7. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ
J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234
[TBL] [Abstract][Full Text] [Related]
8. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin.
Bruewer M; Hopkins AM; Hobert ME; Nusrat A; Madara JL
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C327-35. PubMed ID: 15044152
[TBL] [Abstract][Full Text] [Related]
9. Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier.
Waschke J; Burger S; Curry FR; Drenckhahn D; Adamson RH
Histochem Cell Biol; 2006 Apr; 125(4):397-406. PubMed ID: 16195887
[TBL] [Abstract][Full Text] [Related]
10. The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization.
Schlegel N; Burger S; Golenhofen N; Walter U; Drenckhahn D; Waschke J
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C178-88. PubMed ID: 17989211
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
14. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
[TBL] [Abstract][Full Text] [Related]
15. Rho and Rac but not Cdc42 regulate endothelial cell permeability.
Wójciak-Stothard B; Potempa S; Eichholtz T; Ridley AJ
J Cell Sci; 2001 Apr; 114(Pt 7):1343-55. PubMed ID: 11257000
[TBL] [Abstract][Full Text] [Related]
16. cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.
Pullamsetti SS; Savai R; Schaefer MB; Wilhelm J; Ghofrani HA; Weissmann N; Schudt C; Fleming I; Mayer K; Leiper J; Seeger W; Grimminger F; Schermuly RT
Circulation; 2011 Mar; 123(11):1194-204. PubMed ID: 21382892
[TBL] [Abstract][Full Text] [Related]
17. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.
Achan V; Tran CT; Arrigoni F; Whitley GS; Leiper JM; Vallance P
Circ Res; 2002 Apr; 90(7):764-9. PubMed ID: 11964368
[TBL] [Abstract][Full Text] [Related]
18. The DDAH/ADMA/NOS pathway.
Tran CT; Leiper JM; Vallance P
Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
[TBL] [Abstract][Full Text] [Related]
20. The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis.
Fiedler LR; Wojciak-Stothard B
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1243-7. PubMed ID: 19909255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]